ALT02

trastuzumab · Alteogen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALT02, covering 2017-08-21 to 2017-08-21. Get the full timeline:

Most recent: Clinical Trial Update: A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects [Phase 1]